Search Count: 10
 |
Structural Basis For The Structure-Activity Relationships Of Peroxisome Proliferator-Activated Receptor Agonists
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2007-08-07 Classification: LIGAND BINDING PROTEIN Ligands: DRY |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2007-08-07
Ligands: DRY
 |
Structural Basis For The Structure-Activity Relationships Of Peroxisome Proliferator-Activated Receptor Agonists
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.34 Å Release Date: 2007-08-07 Classification: LIGAND BINDING PROTEIN Ligands: DRD |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2007-08-07
Ligands: DRD
 |
Crystal Structure Of Helicobacter Pylori Undecaprenyl Pyrophosphate Synthase Complexed With Pyrophosphate
Organism: Helicobacter pylori
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2007-06-26 Classification: TRANSFERASE Ligands: DPO |
Organism: Helicobacter pylori
Method: X-RAY DIFFRACTION
Release Date: 2007-06-26
Ligands: DPO
 |
Crystal Structure Of Helicobacter Pylori Undecaprenyl Pyrophosphate Synthase
Organism: Helicobacter pylori
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2006-09-26 Classification: TRANSFERASE |
Organism: Helicobacter pylori
Method: X-RAY DIFFRACTION
Release Date: 2006-09-26
 |
Structure-Based Drug Design And Structural Biology Study Of Novel Nonpeptide Inhibitors Of Sars-Cov Main Protease
Organism: Sars coronavirus
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2006-08-29 Classification: HYDROLASE Ligands: D3F |
Organism: Sars coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2006-08-29
Ligands: D3F
 |
Structure-Based Drug Design And Structural Biology Study Of Novel Nonpeptide Inhibitors Of Sars-Cov Main Protease
Organism: Sars coronavirus
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2006-08-29 Classification: HYDROLASE Ligands: F3F |
Organism: Sars coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2006-08-29
Ligands: F3F
 |
Structure-Based Drug Design And Structural Biology Study Of Novel Nonpeptide Inhibitors Of Sars-Cov Main Protease
Organism: Sars coronavirus
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2006-08-29 Classification: HYDROLASE |
Organism: Sars coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2006-08-29
 |
Structure-Based Drug Design Of A Novel Family Of Ppar Partial Agonists: Virtual Screening, X-Ray Crystallography And In Vitro/In Vivo Biological Activities
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.54 Å Release Date: 2006-05-16 Classification: TRANSCRIPTION ACTIVATOR Ligands: SP0 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2006-05-16
Ligands: SP0
 |
Structure-Based Drug Design Of A Novel Family Of Ppar Partial Agonists: Virtual Screening, X-Ray Crystallography And In Vitro/In Vivo Biological Activities
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2006-05-16 Classification: TRANSCRIPTION ACTIVATOR Ligands: SP3 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2006-05-16
Ligands: SP3
 |
Crystal Structure Of The Ligand Binding Domain Of Human Ppar-Gamma In Complex With An Agonist
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2006-02-14 Classification: TRANSCRIPTION ACTIVATOR Ligands: EHA |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2006-02-14
Ligands: EHA